Shandong Xinhua Pharmaceutical Co Ltd Tangible Net Worth Ratio
Shandong Xinhua Pharmaceutical Co Ltd tangible net worth ratio. Shandong Xinhua Pharmaceutical Co Ltd (000756) has a Tangible Net Worth Ratio of 89.8% as of June 2025. This metric is calculated by deducting intangible assets (CN¥549.65 Million) from net assets (CN¥5.36 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Shandong Xinhua Pharmaceutical Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)
Tangible net worth ratio of Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024. This chart shows how Shandong Xinhua Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 10 annual periods from 2015 to 2024. As of June 2025, the ratio stands at 89.8%, reflecting net assets of CN¥5.36 Billion with intangible assets of CN¥549.65 Million CNY. Check Shandong Xinhua Pharmaceutical Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Shandong Xinhua Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2015–2024)
Shandong Xinhua Pharmaceutical Co Ltd tangible net worth ratio by year from 2015 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Shandong Xinhua Pharmaceutical Co Ltd.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 89.2% | CN¥5.22 Billion | CN¥565.04 Million | CN¥9.02 Billion | ▼ -0.5 pp |
| 2023 | 89.6% | CN¥4.78 Billion | CN¥494.94 Million | CN¥8.29 Billion | ▲ +0.5 pp |
| 2022 | 89.1% | CN¥4.35 Billion | CN¥474.11 Million | CN¥8.27 Billion | ▲ +1.9 pp |
| 2021 | 87.2% | CN¥3.65 Billion | CN¥466.45 Million | CN¥7.33 Billion | ▲ +0.5 pp |
| 2020 | 86.8% | CN¥3.39 Billion | CN¥449.25 Million | CN¥7.09 Billion | ▼ 0.0 pp |
| 2019 | 86.8% | CN¥3.11 Billion | CN¥411.59 Million | CN¥6.44 Billion | ▼ -1.3 pp |
| 2018 | 88.1% | CN¥2.80 Billion | CN¥332.70 Million | CN¥5.92 Billion | ▲ +0.6 pp |
| 2017 | 87.5% | CN¥2.58 Billion | CN¥323.56 Million | CN¥5.27 Billion | ▲ +1.1 pp |
| 2016 | 86.4% | CN¥2.08 Billion | CN¥283.27 Million | CN¥4.72 Billion | ▲ +1.2 pp |
| 2015 | 85.2% | CN¥1.98 Billion | CN¥294.56 Million | CN¥4.49 Billion | — |